Author | Carvalho, Karyne Rangel | |
Author | Chagas, Thiago Pavoni Gomes | |
Author | De Simone, Salvatore Giovanni | |
Access date | 2022-04-30T22:26:47Z | |
Available date | 2022-04-30T22:26:47Z | |
Document date | 2021 | |
Citation | RANGEL, Karyne; CHAGAS, Thiago Pavoni Gomes; DE-SIMONE, Salvatore Giovanni. Acinetobacter baumannii Infections in Times of COVID-19 Pandemic. Pathogens, v. 10, p. 1-13, 2021. | pt_BR |
ISSN | 2076-0817 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/52481 | |
Sponsorship | S.G.S. receives support from the Brazilian Council for Scientific Research (CNPq # 467.488.2014-2; #3075732011; #3013322015-0), Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ # 110.198-13; # 202.841-2018). | pt_BR |
Language | eng | pt_BR |
Publisher | MDPI | pt_BR |
Rights | open access | pt_BR |
Title | Acinetobacter baumannii Infections in Times of COVID-19 Pandemic | pt_BR |
Type | Article | pt_BR |
DOI | 10.3390/pathogens10081006 | |
Abstract | The COVID-19 pandemic has generated an overuse of antimicrobials in critically ill patients. Acinetobacter baumannii frequently causes nosocomial infections, particularly in intensive care units (ICUs), where the incidence has increased over time. Since the WHO declared the COVID-19 pandemic on 12 March 2020, the disease has spread rapidly, and many of the patients infected with SARS-CoV-2 needed to be admitted to the ICU. Bacterial co-pathogens are commonly identified in viral respiratory infections and are important causes of morbidity and mortality. However, we cannot neglect the increased incidence of antimicrobial resistance, which may be attributed to the excess use of antimicrobial agents during the COVID-19 pandemic. Patients with COVID-19 could be vulnerable to other infections owing to multiple comorbidities with severe COVID-19, prolonged hospitalization, and SARS-CoV-2-associated immune dysfunction. These patients have acquired secondary bacterial infections or superinfections, mainly bacteremia and urinary tract infections. This review will summarize the prevalence of A. baumannii coinfection and secondary infection in patients with COVID-19. | pt_BR |
Affilliation | Oswaldo Cruz Foundation. Center for Technological Development in Health. National Institute of Science and Technology for Innovation in Neglected Population Diseases. Rio de Janeiro, RJ, Brazil. | pt_BR |
Affilliation | Federal Fluminense University. Medical School. Department of Pathology. Niterói, RJ, Brazil. | pt_BR |
Affilliation | Federal Fluminense University. Biology Institute. Department of Molecular and Cellular Biology. Niterói, RJ, Brazil. | pt_BR |
Subject | Acinetobacter baumannii | pt_BR |
Subject | infections | pt_BR |
Subject | Antimicrobial resistance | pt_BR |
Subject | COVID-19 | pt_BR |